https://www.prweb.com/releases/pediatric_multicenter_study_shows_targeted_therapy_for_high_risk_hodgkin_lymphoma_reduces_relapse/prweb18997900.htm
0
0
Pediatric Multicenter Study Shows Targeted Therapy for High-Risk Hodgkin Lymphoma Reduces Relapse - PR Web
11/3/22 at 1:48am
Organization
PR Web
48 words
0
Comments
BUFFALO, N.Y., and ATLANTA, Ga. (PRWEB) November 02, 2022 — A targeted therapy for children with high-risk Hodgkin lymphoma (HL) was shown to significantly reduce relapse rates when tested in a l
You are the first to view
Create an account or login to join the discussion